Outrun Therapeutics
PrivateLast Round
Seed
Apr 18, 2024
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Outrun Therapeutics operates in Healthcare & Life Sciences and is based in Dundee. Its latest recorded funding round was a Seed round in April 2024.
Outrun Therapeutics is a biotechnology company that develops small molecule inhibitors targeting E3 ligases for protein stabilization to treat diseases, with a lead program focused on hard-to-treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Outrun Therapeutics Comparables
Compare Outrun Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stablix | 81% | |
| Plexium | 80% | |
| Proxygen | 79% |
For institutional investors. Book with your work email.
Outrun Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Outrun Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MP Healthcare Venture Management | Seed |
| M Ventures | Seed |
| M Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 192% MoM, reaching 1.4K.
- Mar 17, 2026
Lead programme targets HPV positive head and neck cancer.
For institutional investors. Book with your work email.
Outrun Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Outrun Therapeutics's valuation, stock price, and market status.
Is Outrun Therapeutics a public or private company?
Outrun Therapeutics is a private company.
What is the current stock price of Outrun Therapeutics?
Outrun Therapeutics is a private company, so its shares have no public market price. Caplight tracks Outrun Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Outrun Therapeutics worth (valuation)?
Valuation information for Outrun Therapeutics is not publicly available.
Can I buy Outrun Therapeutics stock?
Outrun Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Outrun Therapeutics's last funding round?
Outrun Therapeutics's most recent funding round was Seed on April 18, 2024.
Who are the main investors in Outrun Therapeutics?
Key investors in Outrun Therapeutics include MP Healthcare Venture Management, M Ventures, M Ventures.
Will Outrun Therapeutics IPO soon?
No public IPO plans have been announced for Outrun Therapeutics.
How can I track Outrun Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Outrun Therapeutics's shares on secondary markets.